Source: Annual Congress 2003 - Cell and molecular biology of pulmonary hypertension and COPD
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Beghé, E. Bazzan, F. Calabrese, R. Zuin, G. Turato, S. Baraldo, C. Regorda, C. Schiraldi, F. Rea, P. Maestrelli, L. M. Fabbri, M. Saetta (Padova, Italy). Expression of TGFβ-1 and TGFβ-1RII in pulmonary arteries of patients with severe COPD. Eur Respir J 2003; 22: Suppl. 45, 2538

Member's Comments

No comment yet.

Related content which might interest you: Microvascular changes in COPD patients with severe pulmonary hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD Source: Eur Respir J 2002; 19: 632-638 Year: 2002 Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Versican and collagen-III expression in bronchial and pulmonary muscular arteries in COPD patients Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Do COPD patients have a pulmonary vascular phenotype? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 The effectiveness of pulmonary rehabilitation in Russian patients with COPD complicated by pulmonary artery hypertension Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009 Pulmonary artery hypertension and severity of airflow limitation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Morphology of pulmonary tissue in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 456s Year: 2003 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 microRNAs are deregulated in pulmonary arteries from COPD patients Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Clinical and investigational profiles of elevated pulmonary artery pressures in patients with stable chronic obstructive pulmonary diseases Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Morphometric characteristic of pulmonary artery in COPD and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010 A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)> Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 TGF-β1 type II receptor (TGF-βRII) expression in pulmonary arteries of patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 96s Year: 2005 Role of Rho-kinase pathway in et-1-induced vasoconstriction in pulmonary artery of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009